A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, NON-INFERIORITY CLINICAL TRIAL TO COMPARE THE CLINICAL AND RADIOLOGICAL EFFICACY OF 625 VS. 1250 MG OF ORAL METHYLPREDNISOLONE IN PATIENTS WITH RELAPSE OF MULTIPLE SCLEROSIS: THE ORAL-CORTEM TRIAL